2seventy Bio Stock Buy Hold or Sell Recommendation
TSVT Stock | USD 3.73 0.22 5.57% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding 2Seventy Bio is 'Cautious Hold'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell 2Seventy Bio given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for 2Seventy Bio, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out 2Seventy Bio Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy 2Seventy Stock please use our How to Invest in 2Seventy Bio guide. Note, we conduct extensive research on individual companies such as 2Seventy and provide practical buy, sell, or hold advice based on investors' constraints. 2Seventy Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
2Seventy |
Execute 2Seventy Bio Buy or Sell Advice
The 2Seventy recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on 2Seventy Bio. Macroaxis does not own or have any residual interests in 2Seventy Bio or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute 2Seventy Bio's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
Cautious Hold
Market Performance | Very Weak | Details | |
Volatility | Slightly risky | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very High | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
2Seventy Bio Trading Alerts and Improvement Suggestions
2Seventy Bio generated a negative expected return over the last 90 days | |
2Seventy Bio has high historical volatility and very poor performance | |
2Seventy Bio has a very high chance of going through financial distress in the upcoming years | |
The company reported the previous year's revenue of 100.39 M. Net Loss for the year was (217.57 M) with loss before overhead, payroll, taxes, and interest of (183.46 M). | |
2Seventy Bio currently holds about 357.93 M in cash with (166.86 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 9.45, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
Over 91.0% of the company shares are owned by institutional investors | |
Latest headline from news.google.com: 2seventy bio, Inc. Reports Q3 Loss, Lags Revenue Estimates - MSN |
2Seventy Bio Returns Distribution Density
The distribution of 2Seventy Bio's historical returns is an attempt to chart the uncertainty of 2Seventy Bio's future price movements. The chart of the probability distribution of 2Seventy Bio daily returns describes the distribution of returns around its average expected value. We use 2Seventy Bio price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of 2Seventy Bio returns is essential to provide solid investment advice for 2Seventy Bio.
Mean Return | -0.18 | Value At Risk | -6.58 | Potential Upside | 7.32 | Standard Deviation | 4.51 |
Return Density |
Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of 2Seventy Bio historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
2Seventy Stock Institutional Investors
The 2Seventy Bio's institutional investors refer to entities that pool money to purchase 2Seventy Bio's securities or originate loans. These institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds.
Shares | Geode Capital Management, Llc | 2024-09-30 | 1.2 M | State Street Corp | 2024-09-30 | 1.1 M | Eversept Partners, Llc | 2024-09-30 | 998.1 K | Cowen And Company, Llc | 2024-09-30 | 800 K | Dafna Capital Management Llc | 2024-09-30 | 630 K | Bank Of America Corp | 2024-09-30 | 603.1 K | Healthcare Of Ontario Pension Plan Trust Fund | 2024-09-30 | 590 K | Venator Management Llc | 2024-09-30 | 525 K | Jpmorgan Chase & Co | 2024-09-30 | 514.8 K | Kynam Capital Management, Lp | 2024-09-30 | 6 M | Goldman Sachs Group Inc | 2024-09-30 | 4.2 M |
2Seventy Bio Cash Flow Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Investments | (59.8M) | (22.3M) | 15.4M | 34.5M | (4.6M) | (4.8M) | |
Change In Cash | 267.7M | 90.1M | 163.3M | (59.2M) | 4.4M | 4.2M | |
Free Cash Flow | (267.7M) | (90.1M) | (226.6M) | (260.0M) | (180.7M) | (189.8M) | |
Depreciation | 12.6M | 13.2M | 16.4M | 11.5M | 10.3M | 10.3M | |
Other Non Cash Items | 2.9M | (6.4M) | 869K | 317K | 5.7M | 5.9M | |
Capital Expenditures | 59.8M | 22.3M | 19.6M | 22.8M | 13.9M | 25.2M | |
Net Income | (320.6M) | (120.1M) | (292.2M) | (254.2M) | (217.6M) | (228.4M) | |
Change To Netincome | 64.9M | 54.6M | 55.5M | 41.4M | 37.2M | 41.7M |
2Seventy Bio Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to 2Seventy Bio or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that 2Seventy Bio's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a 2Seventy stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.51 | |
β | Beta against Dow Jones | 2.78 | |
σ | Overall volatility | 4.60 | |
Ir | Information ratio | -0.07 |
2Seventy Bio Volatility Alert
2Seventy Bio exhibits very low volatility with skewness of 0.58 and kurtosis of 1.21. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure 2Seventy Bio's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact 2Seventy Bio's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.2Seventy Bio Fundamentals Vs Peers
Comparing 2Seventy Bio's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze 2Seventy Bio's direct or indirect competition across all of the common fundamentals between 2Seventy Bio and the related equities. This way, we can detect undervalued stocks with similar characteristics as 2Seventy Bio or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of 2Seventy Bio's fundamental indicators could also be used in its relative valuation, which is a method of valuing 2Seventy Bio by comparing valuation metrics with those of similar companies.
Better Than Average | Worse Than Average | Compare 2Seventy Bio to competition |
Fundamentals | 2Seventy Bio | Peer Average |
Return On Equity | -0.52 | -0.31 |
Return On Asset | -0.19 | -0.14 |
Profit Margin | (2.07) % | (1.27) % |
Operating Margin | (0.99) % | (5.51) % |
Current Valuation | 247.47 M | 16.62 B |
Shares Outstanding | 51.59 M | 571.82 M |
Shares Owned By Insiders | 4.05 % | 10.09 % |
Shares Owned By Institutions | 90.75 % | 39.21 % |
Number Of Shares Shorted | 5 M | 4.71 M |
Price To Book | 0.84 X | 9.51 X |
Price To Sales | 4.22 X | 11.42 X |
Revenue | 100.39 M | 9.43 B |
Gross Profit | (183.46 M) | 27.38 B |
EBITDA | (206.42 M) | 3.9 B |
Net Income | (217.57 M) | 570.98 M |
Cash And Equivalents | 357.93 M | 2.7 B |
Cash Per Share | 9.45 X | 5.01 X |
Total Debt | 256.67 M | 5.32 B |
Debt To Equity | 0.73 % | 48.70 % |
Current Ratio | 3.88 X | 2.16 X |
Book Value Per Share | 4.56 X | 1.93 K |
Cash Flow From Operations | (166.86 M) | 971.22 M |
Short Ratio | 14.47 X | 4.00 X |
Earnings Per Share | (1.83) X | 3.12 X |
Target Price | 6.75 | |
Number Of Employees | 274 | 18.84 K |
Beta | 1.79 | -0.15 |
Market Capitalization | 192.42 M | 19.03 B |
Total Asset | 565.43 M | 29.47 B |
Retained Earnings | (511.22 M) | 9.33 B |
Working Capital | 177.99 M | 1.48 B |
Net Asset | 565.43 M |
Note: Disposition of 00 shares by Maus Marcela V. of 2Seventy Bio at 3.3801 subject to Rule 16b-3 [view details]
2Seventy Bio Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as 2Seventy . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
Accumulation Distribution | 18957.26 | |||
Daily Balance Of Power | (0.76) | |||
Rate Of Daily Change | 0.94 | |||
Day Median Price | 3.81 | |||
Day Typical Price | 3.78 | |||
Price Action Indicator | (0.19) | |||
Period Momentum Indicator | (0.22) |
About 2Seventy Bio Buy or Sell Advice
When is the right time to buy or sell 2Seventy Bio? Buying financial instruments such as 2Seventy Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having 2Seventy Bio in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Computers Thematic Idea Now
Computers
Companies that manufacture and distribute personal and business computers. The Computers theme has 44 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Computers Theme or any other thematic opportunities.
View All Next | Launch |
Additional Tools for 2Seventy Stock Analysis
When running 2Seventy Bio's price analysis, check to measure 2Seventy Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 2Seventy Bio is operating at the current time. Most of 2Seventy Bio's value examination focuses on studying past and present price action to predict the probability of 2Seventy Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 2Seventy Bio's price. Additionally, you may evaluate how the addition of 2Seventy Bio to your portfolios can decrease your overall portfolio volatility.